LYN14091 S.L.C. 113TH CONGRESS 2D SESSION - National Organization for Rare Disorders - Document - PDFSEARCH.IO

First Page	Meta Content
	LYN14091 S.L.C. 113TH CONGRESS 2D SESSION Add to Reading List Document Date: 2014-03-04 16:17:18 Open Document File Size: 20,78 KB Share Result on Facebook Anniversary the 30th anniversary of the Orphan Drug Act and the National Organization / / Company LYN14091 S.L.C. / National LYN14091 S.L.C. / / Country United States / / Event FDA Phase / / IndustryTerm treatment for rare diseases / orphan products / / MedicalCondition pulmonary fibrosis / muscular dystrophy / rare diseases / progeria / diseases / spinal muscular atrophy / epidermolysis bullosa / disorder / sickle cell anemia / cystic fibrosis / childhood cancers / rare disease / rare genetic diseases / disorders / / Organization CONGRESS / SENATE OF THE UNITED STATES / Food and Drug Administration / Senate / National Organization for Rare Disorders / / Position advocate for rare disease research / / Product Patient-Focused Drug / / PublishedMedium Public Law / / Technology Drug Development / / SocialTag Pharmaceuticals policy Epidemiology Rare Disease Day Orphan drug Orphan Drug Act National Organization for Rare Disorders Cystic fibrosis Genetic disorder National Institutes of Health Health

LYN14091 S.L.C. 113TH CONGRESS 2D SESSIONAdd to Reading List